Pharmabiz29m
Nona Biosciences updates on its collaborator DualityBio’s ADC collaboration with BeiGene
Nona Biosciences updates on its collaborator DualityBio’s ADC collaboration with BeiGene: Cambridge, Massachusetts Saturday, January 4, 2025, 17:00 Hrs [IST] Nona Biosciences, a ...
Pharmabiz1h
Hanx Biopharma begins patient dosing in Australia for phase 1 trial of HX044 to treat advanced solid tumours
Hanx Biopharma begins patient dosing in Australia for phase 1 trial of HX044 to treat advanced solid tumours: Wuhan, China Saturday, January 4, 2025, 16:00 Hrs [IST] Hanx Biopharm ...
Pharmabiz2h
Capricor Therapeutics seeks US FDA approval for deramiocel for the treatment of Duchenne muscular dystrophy
Capricor Therapeutics seeks US FDA approval for deramiocel for the treatment of Duchenne muscular dystrophy: San Diego Saturday, January 4, 2025, 15:00 Hrs [IST] Capricor Therapeu ...
Pharmabiz3h
China NMPA approves Innovent Biologics’ Dovbleron to treat ROS1-positive non-small cell lung cancer
China NMPA approves Innovent Biologics’ Dovbleron to treat ROS1-positive non-small cell lung cancer: San Francisco Saturday, January 4, 2025, 14:00 Hrs [IST] Innovent Biologics, ...
Pharmabiz4h
NIH-funded study shows aging may change some brain cells more than others
NIH-funded study shows aging may change some brain cells more than others: Bethesda, Maryland Saturday, January 4, 2025, 13:00 Hrs [IST] Based on new brain mapping research funded ...
Pharmabiz7h
Everest Medicines announces the implementation of Nefecon NRDL pricing in China for the treatment for IgA nephropathy
Everest Medicines announces the implementation of Nefecon NRDL pricing in China for the treatment for IgA nephropathy: Shanghai, China Saturday, January 4, 2025, 10:00 Hrs [IST] E ...
Pharmabiz6h
Radius Pharma grants Pharmanovia the exclusive commercialization rights to abaloparatide in China and selected Asia Pacific territories
Radius Pharma grants Pharmanovia the exclusive commercialization rights to abaloparatide in China and selected Asia Pacific territories: Boston, Massachusetts Saturday, January 4, ...
Pharmabiz5h
SIGA Technologies receives Japanese approval for Tepoxx for the treatment of orthopoxviruses
SIGA Technologies receives Japanese approval for Tepoxx for the treatment of orthopoxviruses: New York Saturday, January 4, 2025, 12:00 Hrs [IST] SIGA Technologies, a commercial s ...
Pharmabiz8h
GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps
GSK receives China NMPA approval for Nucala to treat adults with chronic rhinosinusitis with nasal polyps: London, UK Saturday, January 4, 2025, 09:00 Hrs [IST] GSK plc announced ...
Pharmabiz9h
With Exit Examination delayed, PCI asks State Councils to issue D.Pharm registration for one year
Gireesh Babu, New Delhi Saturday, January 4, 2025, 08:00 Hrs [IST] ...
Pharmabiz9h
Telangana DCA conducts raids and seize counterfeit versions of Montek-LC tablets of Sun Pharma
Telangana DCA conducts raids and seize counterfeit versions of Montek-LC tablets of Sun Pharma: Peethaambaran Kunnathoor Chennai Saturday, January 4, 2025, 08:00 Hrs [IST] Acting ...
Pharmabiz9h
Indian healthcare is at a transformative juncture: Dr Gowri Kulkarni
Indian healthcare is at a transformative juncture, with prevention taking centre stage in efforts to combat rising health challenges and chronic diseases. The year 2025 will see a stronger emphasis on ...